drugset / Trial / NCT03351517

Preemptive Tapentadol on Post-operative Analgesia Following Total Knee Arthroplasty

NCT03351517

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study intends to evaluate the efficacy of Tapentadol against placebo as a preemptive analgesic in the management of post-operative pain in the patiens undergoing total knee arthroplasty. The primary objective is to evaluate th epain score in visual analogue scale at various time points within 24 hours post operarively

Timeline

Start
2017-11-01
Primary completion
2018-08-20
Completion
2018-09-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tapentadol Small molecule 100 mg Oral

Indications

No indication recorded.